Description

CG Dimono PTx, developed by Caregen, is the world’s first BBTTXX type C peptide. Leveraging Caregen’s advanced peptide technology and exclusive transdermal delivery system, PTx offers a groundbreaking alternative to traditional BBTTXX type A treatments. Unlike conventional methods, PTx does not require injections and provides efficient, fast, and safe results.
CG Dimono PTx contains hyaluronic acid and an advanced peptide complex that is designed to be injected into the mid-to-deep dermal layer at the site of cutaneous depressions. These components work together to provide a comprehensive dermal filler treatment, ensuring optimal results. The active components work to immediately smooth facial wrinkles and folds while acting as a skinbooster, helping the body to renew and regenerate from within.

Buy other Caregen products here

The pack consists of:

1 syringe x 1ml
1 syringe x 2ml

Composition of the product:

PBS (Phosphate Buffered Saline)
Sodium Hyaluronate (1.0%)
Peptide Complex (Sh-Pentapeptide-12 SP, Octapeptide-11)

Benefits of CG Dimono PTx:

Alternative to traditional BBTTXX type A treatments
Treatment of facial wrinkles, folds, and nasolabial folds
Combine the benefits similar to BBTTXX, dermal fillers, and skin booster in one product

General protocol:

1. Put anesthetic cream to the target areas before injection

2. Injection technique: liner intradermal

3. Injection volume: various in subject conditions
– Entire forehead: 1~2ml
– Nasolabial folds: 0.5~2ml
– Periorbital: 0.5~1ml
– Peri oral: 0.5~1ml
– Lip, Neck, and Chest: 0.5~2ml

4. After injection, put on cold facial mask for 10~20min

1 session for every 2~3 months (Recommend 4~5 sessions/year)